Recent Quotes

Tyme Technologies Inc is the U.S based clinical-stage biotechnology company. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. SM 88, its proprietary drug candidate compound, is a novel compound that has the potential to alter defenses to oxidative stress and increase free radical availability to the cancer cell. The company is currently conducting a Phase II trial in prostate cancer.

Earnings

Q1 2022		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-11
REV		(EXPECTED)2021-08-11

Q4 2021		Est.		Actual		Surprise
EPS				-0.050
REV		5.000M		0		-5.000M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
TYME	Tyme Technologies	1.50	-0.09	-5.66%		255.6M

Tyme Technologies Frequently Asked Questions

How do I buy Tyme Technologies (TYME) stock?

You can purchase shares of Tyme Technologies (NASDAQ: TYME) through any online brokerage.

View our list of the best stock brokerages.

Who are Tyme Technologies's (TYME) competitors?

Other companies in Tyme Technologies’s space includes: AVEO Pharmaceuticals (NASDAQ:AVEO), Innate Pharma (NASDAQ:IPHA), HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR) and Heat Biologics (NASDAQ:HTBX).

What is the target price for Tyme Technologies (TYME) stock?

The latest price target for Tyme Technologies (NASDAQ: TYME) was reported by Canaccord Genuity on January 4, 2018. The analyst firm set a price target for 10.00 expecting TYME to rise to within 12 months (a possible 566.67% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Tyme Technologies (TYME)?

The stock price for Tyme Technologies (NASDAQ: TYME) is $1.5 last updated Fri Jun 11 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Does Tyme Technologies (TYME) pay a dividend?

There are no upcoming dividends for Tyme Technologies.

When is Tyme Technologies (NASDAQ:TYME) reporting earnings?

Tyme Technologies’s Q1 earnings are confirmed for after-market on August 11, 2021.

Is Tyme Technologies (TYME) going to split?

There is no upcoming split for Tyme Technologies.

What sector and industry does Tyme Technologies (TYME) operate in?

Tyme Technologies is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.